On November 21, 2023, Matthew Hill submitted his resignation, effective December 1, 2023, as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of PDS Biotechnology Corporation (the ? Company?) in order to pursue other professional endeavors. Mr. Hill acknowledged that his resignation was not the result of any disagreement relating to the Company?s operations, policies or practices.